BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · IEX Real-Time Price · USD
1.110
+0.080 (7.77%)
At close: Mar 27, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
Pre-market: Mar 28, 2024, 4:30 AM EDT

BioLineRx Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2010
Cash & Equivalents
42.9951.0857.1422.5927.4930.1549.4835.6247.6634.68
Upgrade
Cash & Cash Equivalents
42.9951.0857.1422.5927.4930.1549.4835.6247.6634.68
Upgrade
Cash Growth
-15.83%-10.59%152.96%-17.83%-8.83%-39.07%38.91%-25.26%37.44%90.36%
Upgrade
Receivables
1.190.720.140.140.611.340.590.220.290.26
Upgrade
Inventory
1.95000000000
Upgrade
Other Current Assets
1.050.20.130.150.110.490.310.260.230.22
Upgrade
Total Current Assets
47.185257.422.8828.2131.9850.3836.148.1835.16
Upgrade
Property, Plant & Equipment
1.892.52.282.73.472.232.512.612.910.72
Upgrade
Long-Term Investments
0000001000
Upgrade
Goodwill and Intangibles
14.8521.8921.721.7121.8921.977.020.180.150.12
Upgrade
Other Long-Term Assets
000000.060.060.050.060.22
Upgrade
Total Long-Term Assets
16.7424.3823.9924.4125.3624.2610.592.843.121.05
Upgrade
Total Assets
63.9376.3881.3947.2953.5756.2360.9738.9451.336.21
Upgrade
Accounts Payable
10.876.975.575.927.794.495.522.591.911.65
Upgrade
Deferred Revenue
12.96000000000
Upgrade
Current Debt
3.671.972.933.282.890.90.090.090.090
Upgrade
Other Current Liabilities
3.351.741.231.441.281.361.110.981.141.25
Upgrade
Total Current Liabilities
30.8510.689.7210.6411.976.756.723.663.142.91
Upgrade
Long-Term Debt
7.9210.361.734.47.567.840.160.250.340
Upgrade
Other Long-Term Liabilities
11.934.511.8610.220.660.321.2100.211.5
Upgrade
Total Long-Term Liabilities
19.8514.863.5914.628.228.161.360.250.551.5
Upgrade
Total Liabilities
50.725.5413.325.2620.1914.918.083.913.694.41
Upgrade
Total Debt
11.5912.324.657.6810.468.730.250.340.440
Upgrade
Debt Growth
-5.95%164.98%-39.47%-26.50%19.72%3393.20%-27.11%-21.51%--
Upgrade
Retained Earnings
-390.61-329.99-305.04-277.99-247.97-222.52-199.56-175.21-159.37-144.97
Upgrade
Comprehensive Income
-1.42-1.42-1.42-1.42-1.42-1.42-1.42-1.42-1.42-1.42
Upgrade
Shareholders' Equity
13.2250.8468.0922.0333.3841.3252.8835.0347.6131.81
Upgrade
Net Cash / Debt
31.438.7652.4814.917.0321.4249.2335.2847.2334.68
Upgrade
Net Cash / Debt Growth
-18.98%-26.15%252.17%-12.51%-20.47%-56.50%39.55%-25.30%36.18%90.36%
Upgrade
Net Cash Per Share
0.030.050.080.060.120.200.550.630.921.07
Upgrade
Working Capital
16.3341.3247.6912.2416.2425.2343.6532.4445.0432.25
Upgrade
Book Value Per Share
0.210.981.541.313.425.718.829.3613.8914.71
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).